Profile ng asset

Nu-3 · Lakewood-Amedex Biotherapeutics Inc. (LABT)

Indikasyon
nahawaang diabetic foot ulcers
KumpanyaLABTLakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant ba…

Nasa kalendaryo

Timeline

Pinakabago muna.

Okt 21, 2026
08:02 PM
LABTLakewood-Amedex Biotherapeutics Inc.

Ipinapakita ng Lakewood-Amedex ang Data ng Nu-3 sa IDWeek 2026

Presentasyon sa kumperensyaPress release ng kumpanya

Iba pa mula sa Lakewood-Amedex Biotherapeutics Inc.

Iba pang gamot at kandidato ng parehong kumpanya na sinusubaybayan sa sektor na ito.

Nu-3 · Lakewood-Amedex Biotherapeutics Inc. (LABT) — FDA Timeline at Readiness Checklist | SimianX AI